Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N P Restifo

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1995
Antigen processing in vivo and the elicitation of primary CTL responsesN P Restifo, I Bacík, K R Irvine, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1991
Murine tumor cells transduced with the gene for tumor necrosis factor-alpha. Evidence for paracrine immune effects of tumor necrosis factor against tumorsA L Asher, J J Mulé, A Kasid, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1993
Cytokine secretion by genetically modified nonimmunogenic murine fibrosarcoma. Tumor inhibition by IL-2 but not tumor necrosis factorS E Karp, A Farber, J C Salo, et al.
International Journal of Cancer|February 27, 1999
Natural variation of the expression of HLA and endogenous antigen modulates CTL recognition in an in vitro melanoma modelJ N Cormier, M C Panelli, J A Hackett, et al.
Gene Therapy|May 23, 2008
Development of optimal bicistronic lentiviral vectors facilitates high-level TCR gene expression and robust tumor cell recognitionS Yang, C J Cohen, P D Peng, et al.
The Journal of Experimental Medicine|April 5, 2000
Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: implications for tumor immunotherapyT A Colella, T N Bullock, L B Russell, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 26, 2000
An autologous oral DNA vaccine protects against murine melanomaR Xiang, H N Lode, T H Chao, et al.
Cancer Research|November 3, 2001
Immunization against endogenous retroviral tumor-associated antigensM H Kershaw, C Hsu, W Mondesire, et al.
The Journal of Experimental Medicine|July 22, 1998
gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligandW W Overwijk, A Tsung, K R Irvine, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 17, 1999
Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytesW W Overwijk, D S Lee, D R Surman, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1995
Antigen processing in vivo and the elicitation of primary CTL responsesN P Restifo, I Bacík, K R Irvine, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1991
Murine tumor cells transduced with the gene for tumor necrosis factor-alpha. Evidence for paracrine immune effects of tumor necrosis factor against tumorsA L Asher, J J Mulé, A Kasid, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1993
Cytokine secretion by genetically modified nonimmunogenic murine fibrosarcoma. Tumor inhibition by IL-2 but not tumor necrosis factorS E Karp, A Farber, J C Salo, et al.
International Journal of Cancer|February 27, 1999
Natural variation of the expression of HLA and endogenous antigen modulates CTL recognition in an in vitro melanoma modelJ N Cormier, M C Panelli, J A Hackett, et al.
Gene Therapy|May 23, 2008
Development of optimal bicistronic lentiviral vectors facilitates high-level TCR gene expression and robust tumor cell recognitionS Yang, C J Cohen, P D Peng, et al.
The Journal of Experimental Medicine|April 5, 2000
Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: implications for tumor immunotherapyT A Colella, T N Bullock, L B Russell, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 26, 2000
An autologous oral DNA vaccine protects against murine melanomaR Xiang, H N Lode, T H Chao, et al.
Cancer Research|November 3, 2001
Immunization against endogenous retroviral tumor-associated antigensM H Kershaw, C Hsu, W Mondesire, et al.
The Journal of Experimental Medicine|July 22, 1998
gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligandW W Overwijk, A Tsung, K R Irvine, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 17, 1999
Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytesW W Overwijk, D S Lee, D R Surman, et al.
Pageof 10